ArticleBMC nephrology2016

Treatment with cinacalcet increases plasma sclerostin concentration in hemodialysis patients with secondary hyperparathyroidism.

Piotr Kuczera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.